ANGPTL3 and metabolic dysfunction-associated steatotic liver disease: In this study, Zhao et al. identify Angiopoietin-like 3 (ANGPTL3) as a regulator of hepatic fructose metabolism in metabolic dysfunction-associated steatotic liver disease (MASLD), independent of its known role as an LPL inhibitor, and suggest its potential involvement as a fructose sensor.